Home

arasz iskolai tábla Tengerparti ghit fund for infectious diseases research Visszaélés felszerelés Telepítés

November 4, 2009
November 4, 2009

The Global Health Innovative Technology Fund provides grant to Mitsubishi  Tanabe Pharma and DNDi for Chagas disease and leishman
The Global Health Innovative Technology Fund provides grant to Mitsubishi Tanabe Pharma and DNDi for Chagas disease and leishman

A New Partner for Global Health Innovative Technology (GHIT) Fund
A New Partner for Global Health Innovative Technology (GHIT) Fund

GHIT Fund Announces New Investments: A Total of 790 Million Yen for Product  Development of Neglected Tropical Diseases
GHIT Fund Announces New Investments: A Total of 790 Million Yen for Product Development of Neglected Tropical Diseases

Flood-hit Pakistan faces spread of infectious diseases
Flood-hit Pakistan faces spread of infectious diseases

Joint research identifies hit compounds for the development of a new  treatment for malaria Mitsubishi Tanabe Pharma uses its com
Joint research identifies hit compounds for the development of a new treatment for malaria Mitsubishi Tanabe Pharma uses its com

GHIT Fund secures $20 million pledge from Wellcome | Philanthropy news | PND
GHIT Fund secures $20 million pledge from Wellcome | Philanthropy news | PND

From a Phase 2 TB Vaccine Trial, to Early Work to Neutralize Drug-Resistant  Malaria, $10.7 Million in New Investments from GHIT
From a Phase 2 TB Vaccine Trial, to Early Work to Neutralize Drug-Resistant Malaria, $10.7 Million in New Investments from GHIT

GHIT Fund Archives - Asian Scientist Magazine
GHIT Fund Archives - Asian Scientist Magazine

Multi-country collaboration in responding to global infectious disease  threats: lessons for Europe from the COVID-19 pandemic - The Lancet  Regional Health – Europe
Multi-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemic - The Lancet Regional Health – Europe

GLOBAL HEALTH TECHNOLOGY DISCOVERY AND DEVELOPMENT GHIT Fund Request for  Proposals
GLOBAL HEALTH TECHNOLOGY DISCOVERY AND DEVELOPMENT GHIT Fund Request for Proposals

Estimating the cost of vaccine development against epidemic infectious  diseases: a cost minimisation study - The Lancet Global Health
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study - The Lancet Global Health

Hit and lead criteria in drug discovery for infectious diseases of the  developing world | Nature Reviews Drug Discovery
Hit and lead criteria in drug discovery for infectious diseases of the developing world | Nature Reviews Drug Discovery

Japanese GHIT Fund names new sponsors and funders
Japanese GHIT Fund names new sponsors and funders

Overlooked and underfunded: neglected diseases exert a toll
Overlooked and underfunded: neglected diseases exert a toll

Research-based pharmaceutical industry 360-degree efforts to fight  Neglected Tropical Diseases (NTDs) 2013 - IFPMA
Research-based pharmaceutical industry 360-degree efforts to fight Neglected Tropical Diseases (NTDs) 2013 - IFPMA

GHIT Fund Announces New Investments: A Total of 790 Million Yen for Product  Development of Neglected Tropical Diseases
GHIT Fund Announces New Investments: A Total of 790 Million Yen for Product Development of Neglected Tropical Diseases

A new Korean Research Investment for Global Health Technology (RIGHT) Fund  to advance innovative neglected-disease technologies | PLOS Neglected  Tropical Diseases
A new Korean Research Investment for Global Health Technology (RIGHT) Fund to advance innovative neglected-disease technologies | PLOS Neglected Tropical Diseases

The coronavirus pandemic and US federal investment in science
The coronavirus pandemic and US federal investment in science

What Can a Pharmaceutical Company Do to Save People from Infectious Diseases?  - An interview with Osamu Kunii, CEO of the GHIT Fund - Our Stories -  Daiichi Sankyo
What Can a Pharmaceutical Company Do to Save People from Infectious Diseases? - An interview with Osamu Kunii, CEO of the GHIT Fund - Our Stories - Daiichi Sankyo

Infectious Diseases, Conflict, and Humanitarian Crises | Center for Global  Health Science and Security | Georgetown University
Infectious Diseases, Conflict, and Humanitarian Crises | Center for Global Health Science and Security | Georgetown University

Division of Infectious Diseases and Epidemiology - Penn State College of  Medicine
Division of Infectious Diseases and Epidemiology - Penn State College of Medicine

Global Health Innovative Technology (GHIT) Fund – Global Health Progress
Global Health Innovative Technology (GHIT) Fund – Global Health Progress

Why Global Health R&D | Global Health Innovative Technology Fund
Why Global Health R&D | Global Health Innovative Technology Fund

GHIT Fund secures $20 million pledge from Wellcome | Philanthropy news | PND
GHIT Fund secures $20 million pledge from Wellcome | Philanthropy news | PND

News Detail | Global Health Innovative Technology Fund
News Detail | Global Health Innovative Technology Fund

Why Global Health R&D | Global Health Innovative Technology Fund
Why Global Health R&D | Global Health Innovative Technology Fund